Cosan (CSAN3) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
3 Feb, 2026Executive summary
Q1 2025 saw EBITDA under management of R$5.0 billion, down 30% year-over-year, and a net loss of R$1.8 billion, mainly due to lower equity pickup and operational challenges.
Net debt at Cosan Corporate decreased to R$17.5 billion from R$23.5 billion at 4Q24, driven by the Vale stake sale and liability management.
Major events included the sale of a 4.1% stake in Vale, a fire at Moove's plant, and the acquisition of DIPI Holdings.
Dividends and interest on capital received increased to R$1.5 billion, supporting cash generation.
Safety remained a priority, though fatalities and operational incidents occurred in the quarter.
Financial highlights
Net sales were R$9.66 billion, a 1.8% decrease year-over-year, with a consolidated net loss of R$1.94 billion.
Gross debt at quarter-end was R$21.7 billion, with net debt at R$17.5 billion.
EBITDA under management declined 31% year-over-year to R$5.0 billion.
DSCR improved to 1.2x LTM, and average debt maturity extended to 6.4 years at CDI + 0.91%.
Cash and cash equivalents stood at R$14.8 billion, down from R$16.9 billion at year-end 2024.
Outlook and guidance
Rumo is expected to meet annual guidance, with performance weighted toward the second half due to crop delays.
The company is focused on further deleveraging, capital structure improvement, and operational continuity, especially at Moove and Raízen.
Forward-looking statements are subject to risks from market, economic, political, and regulatory factors.
Latest events from Cosan
- EBITDA and net income fell, but leverage was reduced through asset sales and liability management.CSAN3
Q4 202510 Mar 2026 - EBITDA and net income declined, but R$10.5 billion equity raised improved capital structure.CSAN3
Q3 20253 Feb 2026 - Net loss of R$9.4 billion driven by impairments, with Rumo and Compass showing EBITDA growth.CSAN3
Q4 20243 Feb 2026 - EBITDA fell to R$6.0bn, net loss widened, and leverage rose to 3.4x as segment results diverged.CSAN3
Q2 20253 Feb 2026 - EBITDA grew to R$8.2B, net income fell to R$293M, and management refocused on core business.CSAN3
Q3 20243 Feb 2026 - EBITDA up 15% to R$7.1bn, net loss narrows, but Rumo impairment weighs on results.CSAN3
Q2 20243 Feb 2026